Clinical Evaluation of Inside Echo Patterns in Gray Scale Prostatic Echography

Harada, Kiyomi; Tanahashi, Yoshikatsu; Igari, Dairoku; Numata, Isao; Orikasa, Seiichi

doi:10.1016/s0022-5347(17)55378-1

Cited by 77 publications

(19 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of note, there is a large difference in the detection rate of prostatic calculi using X-rays and that using ultrasonography. Harada et al [26] reported that 80% of calculi are identified with TRUS, but that X-ray only identifies 28% of the calculi. In addition, Peeling et al [27] found that > 70% of prostate calculi images were identified with TRUS, which were not visualized with X-rays.…”

Section: Discussionmentioning

confidence: 99%

Prostate calculi in cancer and BPH in a cohort of Korean men: presence of calculi did not correlate with cancer risk

Hwang¹,

Choi²,

Im³

et al. 2009

Asian J Androl

View full text Add to dashboard Cite

Prostatic calculi are common and are associated with inflammation of the prostate. Recently, it has been suggested that this inflammation may be associated with prostate carcinogenesis. The aim of this study was to investigate the relationship between prostatic calculi and prostate cancer (PCa) in prostate biopsy specimens. We retrospectively analyzed 417 consecutive patients who underwent transrectal ultrasonography (TRUS) and prostate biopsies between January 2005 and January 2008. Based on the biopsy findings, patients were divided into benign prostatic hyperplasia and PCa groups. TRUS was used to detect prostatic calculi and to measure prostate volume. The correlations between PCa risk and age, serum total PSA levels, prostate volume, and prostatic calculi were analyzed. Patient age and PSA, as well as the frequency of prostatic calculi in the biopsy specimens, differed significantly between both the groups (P < 0.05). In the PCa group, the Gleason scores (GSs) were higher in patients with prostatic calculi than in patients without prostatic calculi (P = 0.023). Using multivariate logistic regression analysis, we found that patient age, serum total PSA and prostate volume were risk factors for PCa (P = 0.001), but that the presence of prostatic calculi was not associated with an increased risk of PCa (P = 0.13). In conclusion, although the presence of prostatic calculi was not shown to be a risk factor for PCa, prostatic calculi were more common in patients with PCa and were associated with a higher GS among these men.

show abstract

Section: Discussionmentioning

confidence: 99%

Prostate calculi in cancer and BPH in a cohort of Korean men: presence of calculi did not correlate with cancer risk

Hwang¹,

Choi²,

Im³

et al. 2009

Asian J Androl

View full text Add to dashboard Cite

show abstract

“…Tewari et al [9] concluded that TRUS was inexpensive, easy to use, noninvasive and accurate when compared with MRI. Harada et al [13] showed that the adenoma could be differentiated on TRUS from normal prostatic tissue in patients with BPH, and Jones et al [14] distinguished adenoma from normal prostate using transabdominal ultrasonography. In the present study, adenoma was easily distinguished from total prostate tissue, allowing an estimate of their respective weights.…”

Section: Discussionmentioning

confidence: 99%

The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia

et al. 2000

View full text Add to dashboard Cite

Objective To assess in a prospective study the use of a new variable, the residual prostatic weight ratio (RPWR), for evaluating the clinical outcome after transurethral resection of the prostate (TURP). Patients and methods From April 1996 to June 1997, 40 men (mean age 70.4 years, range 53± 85) with symptomatic benign prostatic hyperplasia were evaluated using the American Urological Association (AUA) symptom score, measurements of the mean and maximum urinary¯ow rate (Q ave and Q max ), and by transrectal ultrasonography (TRUS) before and 16 weeks after TURP. The estimated total prostate weight was derived as 0.52rlengthrwidthrheightrthe speci®c gravity of the prostate (1.010). The RPWR was calculated as the prostate weight after TURP divided by the initial weight, where the value after TURP was the initial weight minus that of the TURP specimen. The clinical outcome was evaluated by the difference (D)in AUA score, Q max and Q ave before and 16 weeks after surgery. Results There was a close correlation between the estimated prostate weight and the actual weight of the TURP specimen (r = 0.82 and 0.80 for the adenoma and total prostate, respectively). The mean (SD) RPWR, DAUA score, DQ max and DQ ave were 50.1 (17.1)%, 11.5 (5.3), 9.0 (4.2) mL/s and 6.2 (2.9) mL/s, respectively. There was a negative correlation between the RPWR and the DAUA, DQ max and DQ ave (r = x0.81, x0.68, and x0.70, respectively, P<0.05). The prostate volume estimated by TRUS decreased signi®cantly 16 weeks after TURP. Conclusions TRUS is a useful tool for estimating prostate weight before surgery. The smaller the RPWR at 16 weeks after TURP, the better the clinical outcome.

show abstract

“…2, 3). The capsular echoes become continuous, while the internal echoes decrease and are symplified (Watanabe et al 1974b(Watanabe et al , 1981Harada et al 1980).…”

Section: Resultsmentioning

confidence: 99%

Evaluation of effect of treatment for primary lesions of stage D2 prostatic cancer by means of transrectal ultrasonotomography.

Ohe

Watanabe

Saitoh

et al. 1986

Tohoku J. Exp. Med.

View full text Add to dashboard Cite

The effect of treatment for primary prostatic lesions of Stage D2 prostatic cancer was evaluated by means of transrectal ultrasonotomography and was compared with that for distant metastatic lesions. A new score system was introduced to assess the effect of treatment for the primary lesions of prostatic cancer from the ultrasonic findings of the prostate on a single examination after treatment. In 19 subjects evaluated as effective or moderate in the treatment of primary lesions, 9 were also evaluated as effective or moderate in the treatment of metastatic lesions, while 10 were judged as poor in the treatment of metastatic lesions. In 12 subjects which were evaluated as poor in the treatment of primary lesions, 3 were judged as moderate in the effect of treatment of metastatic lesions, while 9 were judged as poor. It was proved that the correct evaluation of the primary prostatic tumor was required to perform adequate treatment for Stage D2 prostatic cancer. transrectal ultrasonotomography ; prostatic cancer (Stage D2) ; evaluation of treatment

show abstract

Clinical Evaluation of Inside Echo Patterns in Gray Scale Prostatic Echography

Cited by 77 publications

References 9 publications

Prostate calculi in cancer and BPH in a cohort of Korean men: presence of calculi did not correlate with cancer risk

Prostate calculi in cancer and BPH in a cohort of Korean men: presence of calculi did not correlate with cancer risk

The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia

Evaluation of effect of treatment for primary lesions of stage D2 prostatic cancer by means of transrectal ultrasonotomography.

Contact Info

Product

Resources

About